Twenty percent of eligible youth prescribed GLP-1 receptor agonists

Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the odds of prescription higher with increasing age, increasing body mass index (BMI), and non-Hispanic White or Hispanic race and ethnicity, according to a study published online March 2 in Pediatrics.